Health - Google News: FDA approves Glaxo-Ligand platelet drug for hepatitis C patients - Reuters

Health - Google News Google News

FDA approves Glaxo-Ligand platelet drug for hepatitis C patients - Reuters Nov 19th 2012, 14:40 FDA approves Glaxo-Ligand platelet drug for hepatitis C patients Reuters Mon Nov 19, 2012 9:38am EST. (Reuters) - GlaxoSmithKline Plc said U.S. health regulators had approved its drug Promacta for the additional use of treating hepatitis C patients with a low platelet count who are unable to undergo standard hepatitis C therapy. GlaxoSmithKline Receives FDA Approval For PROMACTARTT News GLAXOSMITHKLINE PLC : FDA approves new indication for PROMACTA ...4-traders all 25 news articles »

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Posted in: